Cancer Risk in Families with Fanconi Anemia
Author Information
Author(s): Marc Tischkowitz, Douglas F Easton, Jan Ball, Shirley V Hodgson, Christopher G Mathew
Primary Institution: Cancer Genetics Program, Departments of Human Genetics and Oncology, Sir M.B. Davis Jewish General Hospital, McGill University, Montreal, Quebec, Canada
Hypothesis
Do relatives of Fanconi Anemia patients have an increased risk of cancer?
Conclusion
This study has not shown a significant difference in overall cancer risk in FA families.
Supporting Evidence
- 55 cancers were reported in FA families compared to an expected incidence of 56.95.
- The relative risk of cancer for FA family members was 0.97.
- 65% of the cancers could be confirmed from death certificates or clinical records.
- No significant differences in cancer risk were found across different carrier probability groups.
Takeaway
The study looked at families with Fanconi Anemia to see if they had more cancer than normal. It found that they didn't have a higher risk overall.
Methodology
Data was collected from 36 families with 575 individuals, focusing on cancer diagnoses and confirming them through various records.
Potential Biases
There may be selection bias as families with perceived higher cancer rates were more likely to participate.
Limitations
The study could have missed some cancers not reported by relatives, and the complementation data for FA families was mostly unavailable.
Participant Demographics
The cohort included 276 males and 299 females from 36 families.
Statistical Information
P-Value
0.62
Confidence Interval
0.71–1.23
Statistical Significance
p=0.62
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website